QA: Global Blood Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001629137_2020_Global_Blood_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001629137, Global Blood Therapeutics Inc

  xvar xval
0 AssetsCurrent 627,997,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 27,113,000
3 remainder_Assets 140,989,000
4 LiabilitiesCurrent 71,453,000
5 LiabilitiesNoncurrent 145,952,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 283,571,000
11 remainder_Revenues 2,108,000
12 remainder_NetIncome 14,697,000
13 remainder_ComprehensiveNetIncome 802,000
  yvar yval
0 Assets 796,099,000
1 Liabilities 217,405,000
2 Expenses 283,571,000
3 Revenues 2,108,000
4 StockholdersEquity 578,694,000
5 NetIncome -266,766,000
6 ComprehensiveNetIncome -266,365,000
7 BaseVar 657,341,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.96
9 EconomicCapitalRatio 3.00

Edgar->Model Mapping

Feature Distribution

Change over Time